Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07834905
What this trial is testing

Nutritional Indices and Inflammatory Markers in MASLD

Who this might be right for
Liver FibrosisMalnutritionNon-Alcoholic Fatty Liver Disease
Assiut University 180
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Large-scale testing (Phase 3)Study completedNCT01980524
What this trial is testing

The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Medical University of Vienna 8
Not applicableUnknownNCT05525884
What this trial is testing

Mechanism of Serum PRL in the Development of MAFLD

Who this might be right for
Type2 DiabetesFatty Liver, NonalcoholicLiver Fibrosis
Shen Qu 1,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07663643
What this trial is testing

Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Cirrhosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 459
Not applicableLooking for participantsNCT05623150
What this trial is testing

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisAlcohol-related Liver Disease+2 more
Institut National de la Santé Et de la Recherche Médicale, France 710
Not applicableNot Yet RecruitingNCT07640880
What this trial is testing

Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV

Who this might be right for
MASLDHIV (Human Immunodeficiency Virus)
Yinzhong Shen 120
Not applicableStudy completedNCT07297225
What this trial is testing

Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model

Who this might be right for
MAFLDCholecystitisGallbladder Polyps+1 more
Zhujiang Hospital 150
Not applicableLooking for participantsNCT05335603
What this trial is testing

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis

Who this might be right for
Chronic Liver Disease
University of Copenhagen 335
Not applicableNot Yet RecruitingNCT07706010
What this trial is testing

Cardiovascular Risk in T2DM With MAFLD: A Cohort Study

Who this might be right for
Type 2 Diabetes (T2DM)Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Hospital of Hangzhou Normal University 7,000
Post-approval studies (Phase 4)Looking for participantsNCT06989723
What this trial is testing

Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver
Seoul National University Bundang Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableNot Yet RecruitingNCT07716995
What this trial is testing

Association Between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaMetabolic Dysfunction-Associated Steatotic Liver Disease
Assiut University 127
Not applicableStudy completedNCT06275906
What this trial is testing

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

Who this might be right for
NAFLDObesityIBS
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 36
Not applicableStudy completedNCT07730736
What this trial is testing

Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome Types

Who this might be right for
Chronic Hepatitis BMetabolic Associated Fatty Liver Disease
Foshan Hospital of Traditional Chinese Medicine 1,000
Not applicableStudy completedNCT03447964
What this trial is testing

Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Groupe Hospitalier Pitie-Salpetriere 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Not applicableStudy completedNCT06338618
What this trial is testing

Manual Therapy in Metabolic Liver Disease

Who this might be right for
NAFLD, Non-alcoholic Fatty Liver Disease
University of Seville 42
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Next Page
114